AdvisorNet Financial, Inc - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 80 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.

Quarter-by-quarter ownership
AdvisorNet Financial, Inc ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2019$1,0001000.0%0.00%
Q3 2019$0
-100.0%
1000.0%0.00%
Q2 2019$1,000
-75.0%
100
-83.9%
0.00%
Q1 2019$4,0000.0%6200.0%0.00%
-100.0%
Q4 2018$4,000
-20.0%
6200.0%0.00%0.0%
Q3 2018$5,000
+66.7%
6200.0%0.00%
Q2 2018$3,000
-25.0%
6200.0%0.00%
-100.0%
Q1 2018$4,0000.0%6200.0%0.00%0.0%
Q4 2017$4,0006200.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2018
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$5,147,0002.57%
ETF MANAGERS GROUP, LLC 14,101,511$14,243,0000.27%
Ikarian Capital, LLC 948,526$968,0000.07%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 289,627$295,0000.04%
Platform Technology Partners 60,000$61,0000.03%
PINNACLE ASSOCIATES LTD 966,014$985,0000.02%
XTX Topco Ltd 41,599$42,0000.01%
Virtu Financial LLC 160,380$164,0000.01%
Tekla Capital Management LLC 413,481$422,0000.01%
Aries Wealth Management 23,400$24,0000.01%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders